Clarius Group’s NGM Biopharmaceuticals NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-26,912
Closed -$42.8K – 502
2024
Q1
$42.8K Buy
26,912
+306
+1% +$454 ﹤0.01% 479
2023
Q4
$22.9K Buy
+26,606
New +$23.4K ﹤0.01% 476

Clarius Group's NGM Position: Q2 2024 in Review

Clarius Group sold out of NGM Biopharmaceuticals (NGM) in Q2 2024, closing a stake of 26,912 shares — an estimated $42.8K sold.

Clarius Group first reported a position in NGM in Q4 2023 and held it in 2 quarters. The position peaked at $42.8K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Clarius Group reported no remaining NGM Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Clarius Group sold 26,912 NGM Biopharmaceuticals shares in Q2 2024, an estimated $42.8K.
  • Clarius Group first reported a position in NGM Biopharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Clarius Group's NGM Biopharmaceuticals position peaked at $42.8K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals as of Q2 2024.

Based on Clarius Group's 13F filing for Q2 2024, filed 11 Jul 2024.